2nd Feb 2006 07:01
Advanced Medical Solutions Grp PLC02 February 2006 For immediate release 2nd February 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") AMS strengthens its commercial organisation to support growth strategy Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that it has strengthened itscommercial organisation and realigned this with the Company's 3-tier route tomarket strategy which comprises branded partners, private label distributors anddirect sales into the NHS. In July 2005, Chris Meredith joined AMS as Group Commercial Director with theobjective of integrating sales, marketing, customer services and businessdevelopment across the Group. Chris formally held senior commercial roleswithin Europe with Banner Pharmacaps and Cardinal Health and gained medicaldevice experience with Smiths Industries. This realignment is now complete and the commercial resources have beenorganised in line with the Company's market and partner focus. Four new sales representatives have recently joined the Company's UK directsales team, which is now focused on selling the Group's LiquiBandTM woundclosure adhesive and its ActivHeal(R) advanced woundcare range into the NHS.LiquiBandTM is the UK market leader in closing wounds in the Accident andEmergency department with adhesives instead of stitches. ActivHeal(R) is avalue range of advanced woundcare products that offers the NHS significant costsavings over branded products for treating routine wounds without compromisingthe quality of patient care. The UK sales group is backed up by a centralmarketing team and clinical nurse advisers to provide necessary training andproduct support to end users. With a substantial part of its business in the US, AMS has recently appointedJeffrey Willis as Vice President of Business Development, based in Columbus,Ohio. Jeff formally held business development roles in Abbott Laboratories andKimberly-Clark Healthcare. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "Over the past few months we have worked hard to recruit and organise a strongintegrated commercial team to support the Group's growth. We are already seeingreal benefits from this renewed focus on commercialising our products andtechnology and are confident of success in 2006." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group